Navigation Links
Patients with oropharyngeal cancer report quality of voice and speech affected post-treatment
Date:2/20/2014

uality," said Jeffrey Vainshtein, MD, lead author of the study and chief resident in the Department of Radiation Oncology at the University of Michigan. "The wide discrepancy between patient- and physician-reporting of voice and speech changes in our study underscores the fact that physicians may tend to underestimate the detrimental effects of head and neck radiation on this aspect of our patients' quality of life. Our findings suggest that minimizing the radiation dose to the voice box and oral cavity in situations where they are not at risk of involvement by cancer is likely to reduce voice and speech problems, and thus improve post-treatment quality of life. Additionally, our research serves as a reminder of the critical role that patient-reported outcomes must continue to play in guiding modifications to our current therapies in order to ultimately improve our patients' quality of life."


'/>"/>
Contact: Michelle Kirkwood
michellek@astro.org
703-286-1600
American Society for Radiation Oncology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. MATH, HPV status in HNSCC patients effective markers of improved patient outcome
2. Researchers look for culprit behind oral health problems in HIV-positive patients
3. Hypnosis therapy shown to decrease fatigue levels in breast cancer patients
4. Bevacizumab (Avastin) fails to improve survival for newly diagnosed glioblastoma patients
5. Blood test serves as crystal ball for heart transplant patients, UCLA-led study finds
6. New treatment proposed to prevent intestinal inflammation in cancer patients
7. One-quarter of high risk patients denied anticoagulation after AF ablation
8. Transgender patients discriminated against for health care services
9. Study finds high Rx burden for bipolar patients
10. NIH study describes new method for tracking T cells in HIV patients
11. Hypertensive patients specialty use changed with medical home
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015 Pipette.com announces their limited ... price is only valid until the end of March ... for a vortex mixer that allows for absolute control ... in 1954 and is headquartered in Bohemia, New York. ... as well as other rockers, incubators, and hybridization ovens ...
(Date:2/27/2015)... February 27, 2015 In New York ... community by providing free dental care from his Sheepshead ... partnered with Dentistry from the Heart, and will be ... The first 50 patients who are in need of ... afford, will have access to high­quality service of Dr. ...
(Date:2/27/2015)... NC (PRWEB) February 27, 2015 The ... leading cancer research funding organizations, is excited to announce ... ways to participate and many long-standing partnerships highlight The ... and focus on expanding ways for all to get ... donations to cutting-edge cancer research, The V Foundation has ...
(Date:2/27/2015)... February 27, 2015 Royal River Natural Foods, ... a new study that found adults who got the most ... 2 diabetes compared to those who got the least magnesium, ... levels. , The report is part of the March 2015 ... Royal River Natural Foods publishes free each month for the ...
(Date:2/27/2015)... 2015 According to court documents, Donna ... June 25, 2013 and underwent a procedure during which ... mouth. Because the duodenoscope allegedly had not been ... “superbug” carbapenem-resistant Enterobacteriaceae (CRE). , A lawsuit ... County on behalf of Ms. Pirolli alleging that Lutheran ...
Breaking Medicine News(10 mins):Health News:Pipette.com Announces Limited Time Offer of 24% Off List Price on the Vortex-Genie 2 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 3Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 2Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 3Health News:New Study Finds Magnesium May Slow Progress of Diabetes, Retailer Reports 2Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2
... to rein in sexual offenders misusing popular networking sites and ... ,Social networking sites allow users to create online profiles with ... to one another and, in many cases, browse other profiles. ... attorneys general from eight states demanded data on registered sex ...
... eastern China have been afflicted with hand, foot and mouth ... news agency Xinhua has reported. ,About 470 patients ... mostly children were still sick with more than half ... the deputy director of the provincial health department. ...
... the government of China has been some heavy handed ... norm. ,The policy - which was launched in ... the world's biggest nation with some 1.3 billion people. ... villagers can have two if the first child is a ...
... the tropical city-state saw a ... first trimester of this year compared to the same period in ... May 12 rose to 1,488, an increase from 993 in the ... ,Experts cite this figure as an all time high, ...
... over New Jerseys claim to the highest autism rate in America, ... provide lifetime care for those with the disorder. A recent ... that about 1 in 152 have the disorder, with the highest ... Jersey. , According to Madeleine Goldfarb, a Livingston mother ...
... Researchers have developed an electronic nose device which may be ... The researchers at Leiden University Medical Center in the Netherlands ... newer version of a sensor that has been used in ... that react to the presence of volatile organic compounds, or ...
Cached Medicine News:Health News:My Space Pressured into Sharing Data on Sex Offenders 2Health News:Aggressive Family Planning Sparks Riots in China 2Health News:Figures of Dengue In Singapore On The Rise 2Health News:American State Lawmakers Make Moves To Tackle Autism 2Health News:Electronic Nose to Diagnose the Severity of Asthma 2
(Date:2/27/2015)... Calif., Feb. 27, 2015 Isis Pharmaceuticals, Inc. ... outperformed both its pro forma net operating loss (NOL) ... a strong financial position.  Isis, significantly improved financial results ... $230 million in payments the Company received from its ... 2014 was a nearly 60% improvement over its 2013 ...
(Date:2/27/2015)... N.J. , Feb. 27, 2015 An ... has helped cut the rate of infection with a ... 40 percent. Clostridium difficile, or C.diff, is ... to life-threatening inflammation of the colon. A recent article ... of Clostridium difficile Infection in the United ...
(Date:2/27/2015)... -- Report Details   Translational ... progress, and predicted revenues ,Where is the market for ... prospects for this market and related technologies? Visiongain,s brand ... to 2025, discussing data, opportunities and prospects. ... medicine : cell-based therapies that aim to restore function ...
Breaking Medicine Technology:Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 3Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8
... , ABBOTT PARK, Ill., Feb. 11 Abbott ... and Drug Administration (FDA) has granted approval of a new tablet ... Norvir tablets can be stored at room temperature and ... Norvir tablets and the Norvir soft-gelatin capsules both contain 100 mg ...
... , , HONG KONG , Feb. ... been enrolled in a randomized clinical trial of the Genous Bio-engineered ... study, the trial will enroll 180 patients split evenly between the ... primary study objective is to demonstrate the safety and effectiveness of ...
Cached Medicine Technology:Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 2Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 3Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 4Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 5Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 6Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 7Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 8Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 9Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 10Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 11Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 12Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets 13OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China 2OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China 3
... The CMGS-1 Color Mini-Ganzfeld Stimulator is ... can be integrated with your existing LKC ... with other visual electrodiagnostic test systems. ... is the smallest commercial Ganzfeld to meet ...
... the most advanced visual electrodiagnostic system ... of retinal and optic nerve function. ... drives this powerful computer-controlled instrument. With ... pattern stimulation, rapid Ganzfeld flash rate ...
... designed to facilitate an arthrodesis, either by ... interbody cages allowing radicular compression by restoring ... and of the foramina, which in turn ... for major lumbar instabilities.,CC cages are made ...
... SHELLGEL is a sterile nonpyrogenic, transparent ... SHELLGEL contains 12 mg/mL of high molecular ... hyaluronate dissolved in physiological saline. In the ... is 105,000 cps (105 Pa s) at ...
Medicine Products: